To assess how a patient with pulmonary arterial hypertension (PAH) is faring on therapy, look at the right heart, said Anjali ...

The following is a summary of “Right atrial reservoir strain as an early predictor of pulmonary hypertension development in ...

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy, ...

Pulmonary artery denervation (PADN), a procedure that targets overactive nerves involved in blood vessel constriction, ...

Treatments approved for PAH may reduce by half the risk of serious complications or death in patients with repaired ...

Mendelian randomization (MR) represents a valuable methodology to address the causal relationships between an exposure and an outcome. In MR studies, instrumental variables associated with the ...

Hypertension does not directly cause dyspnoea; however it can lead to long-term effects on the heart and arteries ...

"Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis" has shed light on the potential of pulmonary artery denervation (PADN) as an innovative intervention for ...

Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis, has shed light on the potential of pulmonary artery denervation (PADN) as an innovative intervention for ...

In the article by Hong et al, “Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension” which was first published on August 21, 2024, and appears in ...

all of whom had moderate to marked pulmonary hypertension. The average pulmonary-artery pressure for this group was 61 systolic, 33 diastolic. Seven patients had failure of the right ventricle ...